ANEBULO PHARMACEUTICALS, INC. Conversion of Stock, Shares Converted
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Conversion of Stock, Shares Converted of 7.28 million shares for the 0-month period ending 2021-05-11, per its 10-K filed 2022-09-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2022-09-09
- 2021-05-11: Conversion of Stock, Shares Converted 0 month 7.28M shares.
| Period end | Conversion of Stock, Shares Converted 0 month |
|---|---|
| 2021-05-11 | 7.28M shares 10-K · filed 2022-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |